Government Affairs Manager &
Women's Health Director

Jamie previously served as the Health Science Strategy and Relations Lead and Health Science Policy Analyst at the NIH Office of Research on Women’s Health (ORWH). In this position, she provided strategic guidance for leadership concerning policy and programmatic challenges in science, health, and the biomedical workforce of significance to the agency. Jamie also conducted a wide range of staff functions involving strategy, visioning, and process planning for the ORWH, and created and maintained several external and internal partnerships. Jamie started at NIH as a Presidential Management Fellow (PMF) Public Health Analyst, serving as the Special Assistant to the Director of ORWH. Prior to working for NIH, she was a Laboratory Analyst who developed methodologies for the destruction of chemical weapons at the Blue Grass Chemical Agent Destruction Pilot program and a Research Chemist at the Center for Disease Control and Prevention (CDC). She has expertise in multiple disciplines, including women’s health innovation, sex, gender, and intersectionality, instrumentation analysis, analytical chemistry, behavioral neuroendocrinology, bioethics, and policy, among a few others. She has published in several peer-reviewed journals. Recently, she served as the Co-Chair of the Innovation Equity Forum that was a joint effort of NIH and the Bill and Melinda Gates Foundation that developed the Women’s Health Innovation Opportunity Map in 2023. Currently, she is on the Advisory Board of the Women’s Health Innovation Series, active member of the MedTech Color Community Collaborative, and on the XPrize Global Visioneering Brain Trust.